Press Releases from Immunotherapeutics (1 total)
CD22: A Suitable Antigen For Targeted Payload Delivery By Immunotherapeutics
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell non-Hodkgina lymphoma (NHL), CD22 expression ranges from…
Go To Page:
